09 March 2001
The Role of Macrophages and Nitric Oxide in the Effector Phase of Allotransplantation Reaction
Vladimir Holan, Magdalena Krulova, Jana Pindjakova, Alena ZajicovaAnn Transplant 2001; 6(1): 44-46 :: ID: 497577
Abstract
Objectives: In spite of the extensive research, the exact mechanism of graft rejection remains not well understood. Since the recipients which have inactivated all known mechanisms of T cell-mediated cytotoxicity can reject allografts, the graft infiltrating macrophages have been considered as a potential effector cell population capable to reject incompatible allografts. Methods: Skin grafts were transplanted in mice in fully allogeneic strain combination or in xenogeneic system and the production of nitric oxide (NO) by graft infiltrating macrophages was determined in graft explants. Results: A significant production of NO was found in rejected allografts and xenografts. The production of NO in graft explants was dependent on the presence of alloimmune T cells and was inhibited by the specific inhibitors of inducible NO synthase. Treatment of allograft recipients with inhibitors of NO synthase enhancedgraftssurvival.Conclusions: T cell-dependent production of NO by graft infiltrating macrophages may represent at least one of the effector mechanisms of allograft and xenograft rejection.
Keywords: Skin Allografts, T cells, Macrophages
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






